BPV(PHEN)
- $73.6 - $274
- Product name: BPV(PHEN)
- CAS: 42494-73-5
- MF: C12H8KN2O5V
- MW: 350.24
- EINECS:
- MDL Number:MFCD32671691
- Synonyms:POTASSIUM BISPEROXO(1,10-PHENANTHROLINE)OXOVANADATE (V);BPV(PHEN);K[VO(O2)2C12H8N2] 3H2O;Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (V) trihydrate;bpV(phen) - CAS 42494-73-5 - Calbiochem
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 10mg
- 25mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberING0014935
- Product descriptionbpV(phen) 95.00%
- Packaging5MG
- Price$233.2
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML0889
- Product descriptionbpV(phen) ≥95% V basis
- Packaging5mg
- Price$73.6
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product number203695
- Product descriptionbpV(phen)
- Packaging10mg
- Price$245
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML0889
- Product descriptionbpV(phen) ≥95% V basis
- Packaging25mg
- Price$274
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | ING0014935 | bpV(phen) 95.00% | 5MG | $233.2 | 2021-12-16 | Buy |
Sigma-Aldrich | SML0889 | bpV(phen) ≥95% V basis | 5mg | $73.6 | 2024-03-01 | Buy |
Sigma-Aldrich | 203695 | bpV(phen) | 10mg | $245 | 2024-03-01 | Buy |
Sigma-Aldrich | SML0889 | bpV(phen) ≥95% V basis | 25mg | $274 | 2024-03-01 | Buy |
Properties
storage temp. :-20°C
solubility :H2O: soluble20mg/mL, clear
form :Yellow solid
color :faint yellow to dark yellow
solubility :H2O: soluble20mg/mL, clear
form :Yellow solid
color :faint yellow to dark yellow
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|